Compare NextEra Energy, Inc. (NEE) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NextEra Energy, Inc. vs Repligen Corporation Common Stock — how do they compare? NextEra Energy, Inc. trades at $78.57 (market cap $163.17B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: NextEra Energy, Inc. is far larger — about 14.6× Repligen Corporation Common Stock's market cap, and NextEra Energy, Inc. pays a 3.19% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NextEra Energy, Inc. for 83 Days and Repligen Corporation Common Stock for 0 Days on average.
| NEE | RGEN | |
|---|---|---|
Market Cap | $163.17B | $11.14B |
Volume | 9,492,162 | 1,259,263 |
Sector | Utilities | Health |
52-Week High | $97.88 | $194.57 |
52-Week Low | $75.49 | $102.87 |
Typical Hold Time | 83 Days | 0 Days |
Enterprise Value | $270.50B | $11.02B |
Dividend Yield | 3.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NextEra Energy (NEE) trades at $78.37, down 0.18% today, with a bullish technical signal but mixed indicators. The company reported strong earnings beats in Q1 and Q2 2026, with revenue growth and a net income margin of 32.4%. Recent news highlights expansion in gas generation and a major infrastructure partnership. Analyst consensus is strongly bullish with a $96 price target, though the stock is near a 52-week low of $74.78, indicating potential value.
Outlook is positive due to robust fundamentals and growth initiatives, but risks include rising debt levels and interest rate sensitivity. The stock offers a dividend yield with upcoming payment, supporting income investors. Upside potential exists if earnings momentum continues, but macroeconomic headwinds and competitive pressures warrant caution.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
